ZOMEDICA PHARMACEUTICALS CORP

NYSE: ZOM (Zomedica Corp.)

最近更新时间: 11 May, 5:10PM

0.100

-0.01 (-7.66%)

前收盘价格 0.108
收盘价格 0.108
成交量 3,594,485
平均成交量 (3个月) 5,529,194
市值 98,093,000
价格/销量 (P/S) 3.97
股市价格/股市净资产 (P/B) 0.520
52周波幅
0.094 (-6%) — 0.195 (94%)
利润日期 13 Mar 2025
营业毛利率 -232.70%
营业利益率 (TTM) -106.33%
稀释每股收益 (EPS TTM) -0.060
季度收入增长率 (YOY) 10.20%
总债务/股东权益 (D/E MRQ) 1.02%
流动比率 (MRQ) 10.82
营业现金流 (OCF TTM) -24.12 M
杠杆自由现金流 (LFCF TTM) -19.19 M
资产报酬率 (ROA TTM) -9.78%
股东权益报酬率 (ROE TTM) -26.82%

市场趋势

短期 中期
行业 Drug Manufacturers - Specialty & Generic (US) 看涨 混合的
Drug Manufacturers - Specialty & Generic (全球的) 看涨 混合的
股票 Zomedica Corp. - -

AIStockmoo 评分

0.6
分析师共识 2.0
内部交易活动 NA
价格波动 -2.0
技术平均移动指标 2.5
技术振荡指标 0.0
平均 0.63

相关股票

股票 市值 DY P/E(TTM) P/B
ZOM 98 M - - 0.520
CPHI 5 M - - 0.940
YCBD 4 M - 0.922 0.740
ZTS 53 B 1.19% 20.34 9.64
TAK 48 B 4.61% 204.29 0.960
HLN 44 B 1.18% 22.51 2.04

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform and VetGuardian, a zero-touch vital signs remote monitoring system, as well as Revo Squared imaging platform comprising diagnostic imaging products and services for use in animal health. It also provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy. The company has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for the development of a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. is headquartered in Ann Arbor, Michigan.

部门 Healthcare
行业 Drug Manufacturers - Specialty & Generic
内部持股比例 1.87%
机构持股比例 9.37%

所有权

姓名 日期 持有股份
West Michigan Advisors, Llc 31 Dec 2024 389,710

该时间范围内无数据。

该时间范围内无数据。

支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明:以上内容仅供参考,并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2025 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票